Skip to main content
Login
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

Maze Therapeutics Announces $150 Million Registered Offering

Summary by Hastings Tribune
SOUTH SAN FRANCISCO, Calif., April 22, 2026 (GLOBE NEWSWIRE) -- Maze Therapeutics, Inc. (Nasdaq: MAZE) today announced the pricing of its underwritten registered offering of 5,540,000 shares of its common stock at a price of $23.50 per share. In addition,…

2 Articles

Hastings TribuneHastings Tribune
Center

Maze Therapeutics Announces $150 Million Registered Offering

SOUTH SAN FRANCISCO, Calif., April 22, 2026 (GLOBE NEWSWIRE) -- Maze Therapeutics, Inc. (Nasdaq: MAZE) today announced the pricing of its underwritten registered offering of 5,540,000 shares of its common stock at a price of $23.50 per share. In addition,…

·Nebraska, United States
Read Full Article
stocktitan.netstocktitan.net

Maze says $150M share sale extends cash runway into 2029

Backed by Farallon and T. Rowe Price, the biotech sold 5.54M shares at $23.50. Maze says the deal will help fund drug R&D and operations into 2029.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

stocktitan.net broke the news on Wednesday, April 22, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

South San Francisco icon

South San Francisco

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal